Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Shares Outstanding (Weighted Average) (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Shares Outstanding (Weighted Average) for 15 consecutive years, with $1.4 million as the latest value for Q3 2024.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 2.73% to $1.4 million in Q3 2024 year-over-year; TTM through Sep 2024 was $1.4 million, a 2.73% decrease, with the full-year FY2023 number at $1.4 million, up 28.76% from a year prior.
  • Shares Outstanding (Weighted Average) was $1.4 million for Q3 2024 at Creative Medical Technology Holdings, down from $1.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $169.2 million in Q2 2020 to a low of $579461.0 in Q4 2020.
  • A 5-year average of $12.7 million and a median of $1.4 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Biggest YoY gain for Shares Outstanding (Weighted Average) was 2283.83% in 2020; the steepest drop was 99.95% in 2020.
  • Creative Medical Technology Holdings' Shares Outstanding (Weighted Average) stood at $579461.0 in 2020, then surged by 349.57% to $2.6 million in 2021, then crashed by 58.04% to $1.1 million in 2022, then rose by 28.76% to $1.4 million in 2023, then decreased by 1.09% to $1.4 million in 2024.
  • Per Business Quant, the three most recent readings for CELZ's Shares Outstanding (Weighted Average) are $1.4 million (Q3 2024), $1.4 million (Q2 2024), and $1.4 million (Q1 2024).